×

MOL BIOL REP 2019 10.1007/s11033-019-05019-8
Anti-leukemic effects of simvastatin on NRAS(G12D) mutant acute myeloid leukemia cells
Jang1, J; Lee, J; Jang, JH; Jung, CW; Park, S

INT J HEMATOL 2019 10.1007/s12185-019-02749-0
Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia
Fujishima1, N; Uchida, T; Onishi, Y; Jung, CW; Goh, YT; Ando, K; Wang, MC; Ono, C; Matsumizu, M; Paccagnella, ML; Sleight, B; Vandendries, E; Fujii, Y; Hino, M

Lancet Haematol 2019 10.1016/S2352-3026(19)30153-X
Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial
Lee1, JW; Lee, SE; Jung, CW; Park, S; Keta, H; Park, SK; Kim, JA; Oh, IH; Jang, JH

GENE CHROMOSOME CANC 2019 10.1002/gcc.22825
Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement
Yoon1, J; Yun, JW; Jung, CW; Ju, HY; Koo, HH; Kim, SH; Kim, HJ

J CLIN LAB ANAL 2019 10.1002/jcla.23064
Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia
Yun1, JW; Yoon, J; Jung, CW; Lee, KO; Kim, JW; Kim, SH; Kim, HJ

J CLIN LAB ANAL 2019 10.1002/jcla.22951
Clonal dominance of a donor-derived del(20q) clone after allogeneic hematopoietic stem cell transplantation in an acute myeloid leukemia patient with del(20q)
Yoon1, J; Yun, JW; Jung, CW; Kim, HJ; Kim, SH

BONE MARROW TRANSPL 2019 10.1038/s41409-019-0492-6
Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD)
Yoon1, JH; Yoo, KH; Sung, KW; Jung, CW; Kim, JS; Hahn, SM; Kang, HJ; Lee, JH; Im, HJ; Ahn, JS; Kook, H; Cho, B; Lee, JW

LEUKEMIA 2019 10.1038/s41375-018-0321-8
HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia
Park1, JH; Woo, YM; Youm, EM; Hamad, N; Won, HH; Naka, K; Park, EJ; Park, JH; Kim, HJ; Kim, SH; Kim, HJ; Ahn, JS; Sohn, SK; Moon, JH; Jung, CW; Park, S; Lipton, JH; Kimura, S; Kim, JW; Kim, D

HAEMATOL-HEMATOL J 2019 10.3324/haematol.2019.218487
Hereditary platelet function disorder from RASGRP2 gene mutations encoding CalDAG-GEFI identified by whole-exome sequencing in a Korean woman with severe bleeding
Yun1, JW; Lee, KO; Jung, CW; Oh, SY; Kim, SH; Choi, CW; Kim, HJ

ANN HEMATOL 2019 10.1007/s00277-019-03624-y
Different prognostic effects of core-binding factor positive AML with Korean AML registry data
Shin1, HJ; Min, WS; Min, YH; Cheong, JW; Lee, JH; Kim, IH; Hong, DS; Ahn, JS; Kim, HJ; Lee, WS; Jung, CW; Jang, JH; Park, Y; Kim, HJ

J CLIN MICROBIOL 2018 10.1128/JCM.00438-18
Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients
Ryu1, MR; Park, MS; Cho, EH; Jung, CW; Kim, K; Kim, SJ; Oh, HY; Huh, W; Jang, HR; Koh, WJ; Park, HY; Kim, YH; Sinn, DH; Choi, JO; Joh, JW; Kim, JM; Kim, SJ; Park, JB; Kang, ES

ANN LAB MED 2018 10.3343/alm.2018.38.6.495
Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia
Kim1, HY; Lee, KO; Park, S; Jang, JH; Jung, CW; Kim, SH; Kim, HJ

BONE MARROW TRANSPL 2018 10.1038/s41409-018-0097-5
Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study
Yoo1, KH; Kang, D; Kim, IR; Choi, EK; Kim, JS; Yoon, SS; Lee, CH; Park, S; Kim, SJ; Kim, K; Kim, WS; Jung, CW; Choi, HJ; Jang, JH; Cho, J

ANN HEMATOL 2018 10.1007/s00277-018-3260-6
Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients
Park1, S; Choi, H; Kim, HJ; Ahn, JS; Kim, HJ; Kim, SH; Mun, YC; Jung, CW; Kim, D

Cancer Med 2018 10.1002/cam4.1450
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea
Shin1, J; Koh, Y; Yoon, SH; Cho, JY; Kim, DY; Lee, KH; Kim, HJ; Ahn, JS; Kim, YK; Park, J; Sohn, SK; Moon, JH; Lee, YJ; Yoon, S; Lee, JO; Cheong, JW; Ha Kim, K; Kim, SH; Kim, HG; Kim, H; Nam, SH; Do, YR; Park, SG; Park, SK; Bae, SH; Song, HH; Shin, DY; Oh, D; Kim, MK; Jung, CW; Park, S; Kim, I

ONCOTARGET 2018 10.18632/oncotarget.23575
Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotype
Ahn1, JS; Kim, HJ; Kim, YK; Lee, SS; Ahn, SY; Jung, SH; Yang, DH; Lee, JJ; Park, HJ; Lee, JY; Choi, SH; Jung, CW; Jang, JH; Kim, HJ; Moon, JH; Sohn, SK; Lee, YJ; Won, JH; Kim, SH; Zhang, ZL; Kim, T; Kim, DDH

CLIN CANCER RES 2017 10.1158/1078-0432.CCR-17-0957
Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
Kwak1, JY; Kim, SH; Oh, SJ; Zang, DY; Kim, H; Kim, JA; Do, YR; Kim, HJ; Park, JS; Choi, CW; Lee, WS; Mun, YC; Kong, JH; Chung, JS; Shin, HJ; Kim, DY; Park, J; Jung, CW; Bunworasate, U; Comia, NS; Jootar, S; Reksodiputro, AH; Caguioa, PB; Lee, SE; Kim, DW

KOREAN JOURNAL OF INTERNAL MEDICINE 2017 10.3904/kjim.2015.406
Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea
Kim1, HS; Kim, HJ; Kim, SH; Choi, JY; Ko, YH; Kim, WS; Jung, CW; Kim, SJ

Nutrition. 2017 Apr;36:67-71. doi: 10.1016/j.nut.2016.06.009. Epub 2016 Jun 25.
Patient-Generated Subjective Global Assessment as a prognosis tool in patients with multiple myeloma
Kim HS11, Lee JY2, Lim SH2, Cho J3, Kim SJ2, Jang JH2, Kim WS2, Jung CW2, Kim K4.

Oncotarget. 2017 Jan 31;8(5):8305-8314. doi: 10.18632/oncotarget.14171.
5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia
Ahn JS11,2, Kim HJ1,2, Kim YK1,2, Lee SS1, Ahn SY1, Jung SH1, Yang DH1, Lee JJ1, Park HJ2, Choi SH2, Jung CW3, Jang JH3, Kim HJ4, Moon JH5, Sohn SK5, Won JH6, Kim SH7, Michael S8, Minden MD9, Kim DD9.